Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Net Cash Flow (2023 - 2025)

Vsee Health's Net Cash Flow history spans 3 years, with the latest figure at $4.8 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 339.53% year-over-year to $4.8 million; the TTM value through Dec 2025 reached $4.9 million, up 2460.22%, while the annual FY2025 figure was $4.9 million, 2282.17% up from the prior year.
  • Net Cash Flow reached $4.8 million in Q4 2025 per VSEE's latest filing, up from $181164.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $4.8 million in Q4 2025 to a low of -$2.0 million in Q4 2024.
  • Average Net Cash Flow over 3 years is $420147.4, with a median of $84007.0 recorded in 2025.
  • The largest YoY upside for Net Cash Flow was 1316.78% in 2024 against a maximum downside of 4804.48% in 2024.
  • A 3-year view of Net Cash Flow shows it stood at -$40804.0 in 2023, then plummeted by 4804.48% to -$2.0 million in 2024, then skyrocketed by 339.53% to $4.8 million in 2025.
  • Per Business Quant, the three most recent readings for VSEE's Net Cash Flow are $4.8 million (Q4 2025), $181164.0 (Q3 2025), and -$118527.0 (Q2 2025).